Brain Amino Acid Requirements and Toxicity: The Example of Leucine
Open Access
- 1 June 2005
- journal article
- review article
- Published by Elsevier BV in Journal of Nutrition
- Vol. 135 (6), 1531S-1538S
- https://doi.org/10.1093/jn/135.6.1531s
Abstract
Glutamic acid is an important excitatory neurotransmitter of the brain. Two key goals of brain amino acid handling are to maintain a very low intrasynaptic concentration of glutamic acid and also to provide the system with precursors from which to synthesize glutamate. The intrasynaptic glutamate level must be kept low to maximize the signal-to-noise ratio upon the release of glutamate from nerve terminals and to minimize the risk of excitotoxicity consequent to excessive glutamatergic stimulation of susceptible neurons. The brain must also provide neurons with a constant supply of glutamate, which both neurons and glia robustly oxidize. The branched-chain amino acids (BCAAs), particularly leucine, play an important role in this regard. Leucine enters the brain from the blood more rapidly than any other amino acid. Astrocytes, which are in close approximation to brain capillaries, probably are the initial site of metabolism of leucine. A mitochondrial branched-chain aminotransferase is very active in these cells. Indeed, from 30 to 50% of all α-amino groups of brain glutamate and glutamine are derived from leucine alone. Astrocytes release the cognate ketoacid [α-ketoisocaproate (KIC)] to neurons, which have a cytosolic branched-chain aminotransferase that reaminates the KIC to leucine, in the process consuming glutamate and providing a mechanism for the “buffering” of glutamate if concentrations become excessive. In maple syrup urine disease, or a congenital deficiency of branched-chain ketoacid dehydrogenase, the brain concentration of KIC and other branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate–aspartate shuttle and a diminished rate of protein synthesis.Keywords
This publication has 73 references indexed in Scilit:
- Intercellular metabolic compartmentation in the brain: past, present and futureNeurochemistry International, 2004
- Expression of monocarboxylic acid transporters (MCT) in brain cells: Implication for branched chain α-ketoacids transport in neuronsNeurochemistry International, 2003
- Interrelationships of Leucine and Glutamate Metabolism in Cultured AstrocytesJournal of Neurochemistry, 1994
- Intellectual outcome in children with maple syrup urine diseaseThe Journal of Pediatrics, 1991
- Cerebral edema causing death in children with maple syrup urine diseaseThe Journal of Pediatrics, 1991
- Maple syrup urine disease: Interrelations between branched‐chain amino‐, oxo‐ and hydroxyacids; implications for treatment; associations with CNS dysmyelinationJournal of Inherited Metabolic Disease, 1991
- Precursors of glutamic acid nitrogen in primary neuronal cultures: Studies with15NNeurochemical Research, 1990
- [ 15 N] leucine as a source of [ 15 N] glutamate in organotypic cerebellar explantsBiochemical and Biophysical Research Communications, 1983
- Inhibition, by 2‐Oxo Acids That Accumulate in Maple‐Syrup‐Urine Disease, of Lactate, Pyruvate, and 3‐Hydroxybutyrate Transport Across the Blood‐Brain BarrierJournal of Neurochemistry, 1982
- TRANSCRIPTION OF REPEATED AND UNIQUE DNA SEQUENCES IN BRAIN NUCLEIJournal of Neurochemistry, 1976